Experiment: 2LSY

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	0.9 mM [U-99% 13C; U-99% 15N] REV1-CT, 50 mM sodium phosphate, 100 mM sodium chloride, 0.25 mM EDTA, 5 mM DTT, 0.05 % sodium azide, 90 % H2O, 10 % [U-2H] D2O	90% H2O/10% D2O	100	7.0	ambient	288
2	3D HNCO	0.9 mM [U-99% 13C; U-99% 15N] REV1-CT, 50 mM sodium phosphate, 100 mM sodium chloride, 0.25 mM EDTA, 5 mM DTT, 0.05 % sodium azide, 90 % H2O, 10 % [U-2H] D2O	90% H2O/10% D2O	100	7.0	ambient	288
3	3D HNCACB	0.9 mM [U-99% 13C; U-99% 15N] REV1-CT, 50 mM sodium phosphate, 100 mM sodium chloride, 0.25 mM EDTA, 5 mM DTT, 0.05 % sodium azide, 90 % H2O, 10 % [U-2H] D2O	90% H2O/10% D2O	100	7.0	ambient	288
4	3D HNCA	0.9 mM [U-99% 13C; U-99% 15N] REV1-CT, 50 mM sodium phosphate, 100 mM sodium chloride, 0.25 mM EDTA, 5 mM DTT, 0.05 % sodium azide, 90 % H2O, 10 % [U-2H] D2O	90% H2O/10% D2O	100	7.0	ambient	288
5	3D 1H-15N NOESY	0.9 mM [U-99% 13C; U-99% 15N] REV1-CT, 50 mM sodium phosphate, 100 mM sodium chloride, 0.25 mM EDTA, 5 mM DTT, 0.05 % sodium azide, 90 % H2O, 10 % [U-2H] D2O	90% H2O/10% D2O	100	7.0	ambient	288
6	2D 1H-13C HSQC aliphatic	0.9 mM [U-99% 13C; U-99% 15N] REV1-CT, 50 mM sodium phosphate, 100 mM sodium chloride, 0.25 mM EDTA, 5 mM DTT, 0.05 % sodium azide, 90 % H2O, 10 % [U-2H] D2O	90% H2O/10% D2O	100	7.0	ambient	288
7	2D 1H-13C HSQC aromatic	0.9 mM [U-99% 13C; U-99% 15N] REV1-CT, 50 mM sodium phosphate, 100 mM sodium chloride, 0.25 mM EDTA, 5 mM DTT, 0.05 % sodium azide, 90 % H2O, 10 % [U-2H] D2O	90% H2O/10% D2O	100	7.0	ambient	288
8	3D 1H-13C NOESY aromatic	0.9 mM [U-99% 13C; U-99% 15N] REV1-CT, 50 mM sodium phosphate, 100 mM sodium chloride, 0.25 mM EDTA, 5 mM DTT, 0.05 % sodium azide, 90 % H2O, 10 % [U-2H] D2O	90% H2O/10% D2O	100	7.0	ambient	288
9	3D 1H-13C NOESY aliphatic	0.9 mM [U-99% 13C; U-99% 15N] REV1-CT, 50 mM sodium phosphate, 100 mM sodium chloride, 0.25 mM EDTA, 5 mM DTT, 0.05 % sodium azide, 90 % H2O, 10 % [U-2H] D2O	90% H2O/10% D2O	100	7.0	ambient	288
10	3D HBHA(CO)NH	0.9 mM [U-99% 13C; U-99% 15N] REV1-CT, 50 mM sodium phosphate, 100 mM sodium chloride, 0.25 mM EDTA, 5 mM DTT, 0.05 % sodium azide, 90 % H2O, 10 % [U-2H] D2O	90% H2O/10% D2O	100	7.0	ambient	288
11	3D HCCH-TOCSY	0.9 mM [U-99% 13C; U-99% 15N] REV1-CT, 50 mM sodium phosphate, 100 mM sodium chloride, 0.25 mM EDTA, 5 mM DTT, 0.05 % sodium azide, 90 % H2O, 10 % [U-2H] D2O	90% H2O/10% D2O	100	7.0	ambient	288

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Varian	INOVA	500
2	Varian	INOVA	800

NMR Refinement
Method	Details	Software
simulated annealing		CARA

NMR Ensemble Information
Conformer Selection Criteria	all calculated structures submitted
Conformers Calculated Total Number	20
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	chemical shift assignment	CARA		Keller and Wuthrich
2	data analysis	CARA		Keller and Wuthrich
3	peak picking	CARA		Keller and Wuthrich
4	structure solution	CYANA		Guntert, Mumenthaler and Wuthrich
5	data analysis	MOLMOL		Koradi, Billeter and Wuthrich
6	collection	VnmrJ		Varian
7	refinement	CNS		Brunger, Adams, Clore, Gros, Nilges and Read
8	processing	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.